Member Info for Wigster77

Just beat me to it grazzyman :-)

https://www.synairgen.com/science/covid-19

SG018 completed recruitment in November 2021. You can read the press release here: Synairgen completes Phase III recruitment

No press release.

If you register on the FinnCap site you can access their latest report into Synairgen. They have positive data getting us to around £7.30/share, with government stockpiling raising this somewhere around £25 - £75 per share.

Another broker, Numis, has the bull case at £85/share.

All really depends on how good the P3 data is, EUA's then size of orders globally. Also throw potential joint ventures and takeovers into the mix. Suffice to say, once the first hurdle of good P3 is over it's only going in one direction.

Don't panic - the government are already preparing the next super-duper variant to knacker our Easter. They're going to call it the mEGGertron variant...

I'll get my coat...

BeContrarian - someone posted this a couple of weeks ago (thank you) and it backs up your point.

https://www.fiercebiotech.com/biotech/tidy-up-your-labs-biotech-pfizer-coming-significant-firepower-and-cash-to-burn

Ghia's advice is correct...and RM won't let it go cheap if p3 results are as good as we are all hoping. He's already said so.

In my opinion £10Bn would be an absolute bargain (£50/share), with £15-20Bn being nearer the mark, but obviously depends on that p3 and subsequent orders etc.

If p3 is a roaring success government ministers will all be coming out of the woodwork telling everyone that they've offered Synairgen unwavering support non stop for the last 3 years plus...

Indeed: all numbers ABOVE 13 are unlucky for me. Over to you Synairgen :-)

£137.23/share - market cap roughly £27Bn. Perfectly reasonable for the potential of this treatment for all variants of Covid past present and future, SARS, COPD, Asthma, Common Cold etc.

Are you listening Mr Pfizer/AZ etc?

We'll take £25Bn for a quick sale :-P

If I had a pound for everytime I'd read "January 4th brigade" I wouldn't need to be invested in this stock :-P ...

Indeed. On successful p3, and given the breadth of potential for SNG (covid variants, COPD, asthma, common cold etc), one could argue that $15Bn would be a very cheap buy for the Pfizers and Astra Zenecas of this world...

7:03 Tues 25th Jan where closing price on the Monday will be 202.4

I've tried looking for that word on numerous occasions TL...could never find it.

There are bits and pieces out there about Synairgen Gold5, but yes it is limited. I, like many other eager shareholders, get impatient there's not been more news/info out there, but I think this is simply due to Synairgen dilligently following the P3 process and not jumping the gun with ifs, buts, maybes and potential false positives like a lot of their competitors do. Rest assured, if the results are as good as we are all hoping (or at least good enough to make a real medical difference) then we will be hearing about it through every media outlet throughout the world. This could save so many lives - it won't be kept a secret. Hopfully not long to wait now!!! GLA.

The answer is 9 letters long and begins with "S". You can even make the word "easy" out of it...

Tomorrow: England beat Australia
Tuesday: RNS - P3 results announced, 99% efficacy - share price hits £12
Wednesday: RNS - SNG001 "smashes Delta and Omicron to bits" - share price hits £25
Thursday: RNS - multiple orders from governments globally. Joe Biden offers $10Bn premium for US to be first in queue even though it was anyway. Share price now north of £50.
Friday: Boris Johnson announces that, thanks to a British company - whose name he can't remember, but the which the government have staunchly supported for decades - lockdowns and any future restrictions may be cancelled from January, but he will confirm when he gets back from the Tory Christmas Party and sobers up.
Saturday: Richard Marsden & Synairgen the focus of the Queen's speech.

Well, you never know... GLA :-)

Hopefully so. If P3 results are as good as we are all hoping, then a £10Bn purchase by one of the big-boys could start to look like an absolute steal for them, without even considering any other of the Omicron/COPD/Asthma benefits which SNG will hopefully provide.

I'd be tempted at £42!! That's still loose change to a company like Pfizer, so possible on stellar P3 results I guess. GLA.

I think Synairgen break up for Christmas on the 15th :-P